Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 7,364 | 6,457 | 5,722 | 5,193 | 4,612 |
| Cost of Goods | 912 | 971 | 582 | 589 | 772 |
| Gross Profit | 6,452 | 5,486 | 5,140 | 4,604 | 3,840 |
| Operating Expenses | 15,538 | 18,129 | 20,026 | 23,809 | 16,046 |
| Operating Income | -8,174 | -11,672 | -14,304 | -18,616 | -11,434 |
| Interest Expense | 877 | 3 | 3 | 4 | 4 |
| Other Income | 4,726 | -1,528 | -21,388 | 17,195 | -2,523 |
| Pre-tax Income | -4,325 | -13,203 | -35,695 | -1,425 | -13,961 |
| Income Tax | -7 | -3 | 1 | 0 | 13 |
| Net Income Continuous | -4,318 | -13,200 | -35,696 | -1,425 | -13,974 |
| Net Income | $-4,332 | $-13,206 | $-35,696 | $-1,425 | $-13,974 |
| EPS Basic Total Ops | -0.21 | -0.60 | 29.78 | -0.14 | -35.84 |
| EPS Basic Continuous Ops | -0.18 | -0.57 | 25.63 | -0.11 | -31.33 |
| EPS Diluted Total Ops | -0.21 | -0.60 | 29.78 | -0.14 | -35.84 |
| EPS Diluted Continuous Ops | -0.18 | -0.57 | 25.63 | -0.11 | -31.33 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.54 | -1.56 | N/A | N/A |
| EBITDA(a) | $-7,713 | $-11,497 | $-14,110 | $-18,460 | $-11,284 |